Aurobindo Pharma USA is voluntarily recalling one lot of Gabapentin Capsules because the bottles contain some empty capsules. Empty capsules could result in patients missing doses, which would result in adverse health consequences that range from no effect, short term withdrawal effect, or status epilepticus (long period seizures) that could be life-threatening. No reports of adverse health events have been reported to date.
Gabapentin is used for the treatment of epilepsy and for the management of postherpetic neuralgia (pain after shingles). The product is sold in 300 mg 100-count bottles. The lot number is GESB14011-A, the expiration date is 12/2015, and the NDC is 16714-662-01. The product has the imprint D on the yellow cap and 03 on yellow body with black edible ink. The product was distributed through the Northstar label to retail outlets nationwide.
If you have this product, do not consume it. Return it to the place of purchase for a refund. If you have experienced any adverse health effects, see your doctor and report the problems to the FDA’s MedWatch Adverse Event Reporting program.
